Silver Book Fact

Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.

Cuatrecasas G, Alegre C, Fernandez-Sola J, et al. Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia. Pain. 2012; 153(7): 1382-9. http://www.ncbi.nlm.nih.gov/pubmed/22465047

Reference

Title
Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia
Publication
Pain
Publication Date
2012
Authors
Cuatrecasas G, Alegre C, Fernandez-Sola J, et al
Volume & Issue
Volume 153, Issue 7
Pages
1382-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The combination of information for neuroimaging and circulatory biomarkers could improve both the sensitivity and specificity of pain diagnosis and thereby improve treatment.  
  • Pregalbin, an antiepileptic drug, produced around a 32% pain reduction (a significant reduction) at week 16 versus around 20% for placebo, in patients with neuropathic pain due to spinal cord…  
  • Exercise has shown to be effective in reducing persistent pain from osteoarthritis of the knee.  
  • Advances in neuroimaging will continue to offer information on the brain’s functioning and how it correlates to the pain experience.  
  • Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.